Unveiling immune-metabolic interaction in Atherosclerosis via Comprehensive Landscape of Hub Genes and Immune Microenvironment
DOI:
https://doi.org/10.59958/hsf.5925Keywords:
atherosclerosis, hub genes, immunoregulatory, metabolismAbstract
Objective: Atherosclerosis (AS) as a major cause of cardiovascular diseases, is considered a chronic inflammatory disease and accelerates by inflammation, lipid metabolism disorder and other mechanisms. AS pathogenesis and its relationship with immune regulation and metabolic interactions is still not fully elucidated. The purpose of this study is to delve into the correlation between mitochondrial metabolism and immunity in AS, and identify potential therapeutic targets for clinical treatment. Methods: Hub genes associated with mitochondrial metabolism and the pathogenesis of AS were identified by performing differentially expressed genes (DEGs) analysis and Weighted Gene Co-expression Network Analysis (WGCNA) based on two gene expression datasets (GSE100927 and GSE43292). And the biological processes and pathways of DEGs were determined through gene ontology (GO) and Gene Set Enrichment Analysis (GSEA) analysis. Then stepwise regression, random forest, and Lasso regression machine learning were used to evaluate the diagnostic value of hub genes. After that, the immune infiltration and single cell sequencing dataset GSE184073 were analyzed, and the immune cell composition in peripheral blood from AS patients using Mass Cytometry were detected to further consider the influence of immunoregulation. Results: Ten hub genes associated with mitochondrial metabolism and AS pathogenesis were identified, including NDUFS4, AIFM3, IDUA, TNF, CHKA, SLC11A1, SLC35C1, SLC37A2, ARSB, SLC16A5. GO and GSEA analysis showed their correlation with immunity and inflammation. Lasso regression revealed that TNF and ARSB had relatively good diagnostic performance. Further exploration was conducted on the expression of these hub genes in the immune microenvironment and their correlation with different immune factors. Mass cytometry demonstrated the influence of the vascular immune microenvironment on the pathogenesis of AS. Conclusions: Our study provides a more comprehensive understanding of the complex relationships between immune and metabolic factors and their impact on the microenvironment of AS. The identification of hub genes in AS may provide new targets for therapeutic intervention.
References
Ross R. Atherosclerosis–an inflammatory disease. The New England Journal of Medicine. 1999; 340: 115–126.
Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, et al. Non-coronary atherosclerosis. European Heart Journal. 2014; 35: 1112–1119.
Libby P. The changing landscape of atherosclerosis. Nature. 2021; 592: 524–533.
Gisterå A, Hansson GK. The immunology of atherosclerosis. Nature Reviews. Nephrology. 2017; 13: 368–380.
Jukema RA, Ahmed TAN, Tardif JC. Does low-density lipoprotein cholesterol induce inflammation? If so, does it matter? Current insights and future perspectives for novel therapies. BMC Medicine. 2019; 17: 197.
Bäck M, Yurdagul A, Jr, Tabas I, Öörni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nature Reviews. Cardiology. 2019; 16: 389–406.
Torzewski M. The Initial Human Atherosclerotic Lesion and Lipoprotein Modification-A Deep Connection. International Journal of Molecular Sciences. 2021; 22: 11488.
Wei Y, Corbalán-Campos J, Gurung R, Natarelli L, Zhu M, Exner N, et al. Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism. Circulation. 2018; 138: 2007–2020.
Kubo T, Maehara A, Mintz GS, Doi H, Tsujita K, Choi SY, et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. Journal of the American College of Cardiology. 2010; 55: 1590–1597.
Tabas I, Bornfeldt KE. Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis. Circulation Research. 2020; 126: 1209–1227.
Röszer T. Transcriptional control of apoptotic cell clearance by macrophage nuclear receptors. Apoptosis: an International Journal on Programmed Cell Death. 2017; 22: 284–294.
Tabas I, Bornfeldt KE. Macrophage Phenotype and Function in Different Stages of Atherosclerosis. Circulation Research. 2016; 118: 653–667.
Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, et al. Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. American Journal of Physiology. Endocrinology and Metabolism. 2015; 308: E756–E769.
Björnheden T, Bondjers G. Oxygen consumption in aortic tissue from rabbits with diet-induced atherosclerosis. Arteriosclerosis. 1987; 7: 238–247.
Roy P, Orecchioni M, Ley K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nature Reviews of Immunology. 2022; 22: 251–265.
Zhong Z, Wu H, Zhang Q, Zhong W, Zhao P. Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing. Journal of Translational Medicine. 2019; 17: 21.
Ketelhuth DFJ, Hansson GK. Adaptive Response of T and B Cells in Atherosclerosis. Circulation Research. 2016; 118: 668–678.
Libby P, Hansson GK. From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week. Journal of the American College of Cardiology. 2019; 74: 1594–1607.
Kyaw T, Tay C, Krishnamurthi S, Kanellakis P, Agrotis A, Tipping P, et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circulation Research. 2011; 109: 830–840.
Taminau J, Meganck S, Lazar C, Steenhoff D, Coletta A, Molter C, et al. Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R/Bioconductor packages. BMC Bioinformatics. 2012; 13: 335.
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007; 8: 118–127.
Birsoy K, Wang T, Chen WW, Freinkman E, Abu-Remaileh M, Sabatini DM. An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis. Cell. 2015; 162: 540–551.
Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022; 375: 1254–1261.
Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011; 27: 1739–1740.
Lai D, Tan L, Zuo X, Liu D, Jiao D, Wan G, et al. Prognostic Ferroptosis-Related lncRNA Signatures Associated With Immunotherapy and Chemotherapy Responses in Patients With Stomach Cancer. Frontiers in Genetics. 2022; 12: 798612.
Ru B, Wong CN, Tong Y, Zhong JY, Zhong SSW, Wu WC, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019; 35: 4200–4202.
Muhammad K, Ayoub MA, Iratni R. Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander? Current Pharmaceutical Design. 2021; 27: 2141–2150.
Lacy M, Atzler D, Liu R, de Winther M, Weber C, Lutgens E. Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis. Pharmacology & Therapeutics. 2019; 193: 50–62.
Koskimäki J, Girard R, Li Y, Saadat L, Zeineddine HA, Lightle R, et al. Comprehensive transcriptome analysis of cerebral cavernous malformation across multiple species and genotypes. JCI Insight. 2019; 4: e126167.
Chmielowski RA, Abdelhamid DS, Faig JJ, Petersen LK, Gardner CR, Uhrich KE, et al. Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation. Acta Biomaterialia. 2017; 57: 85–94.
Cunrath O, Bumann D. Host resistance factor SLC11A1 restricts Salmonella growth through magnesium deprivation. Science. 2019; 366: 995–999.
Xu H, Zhang A, Fang C, Zhu Q, Wang W, Liu Y, et al. SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma. Frontiers in Immunology. 2022; 13: 980378.
Ma PY, Tan JE, Hee EW, Yong DWX, Heng YS, Low WX, et al. Human Genetic Variation Influences Enteric Fever Progression. Cells. 2021; 10: 345.
Haschka D, Hoffmann A, Weiss G. Iron in immune cell function and host defense. Seminars in Cell & Developmental Biology. 2021; 115: 27–36.
Fu D, Zhang Z, Wallrad L, Wang Z, Höller S, Ju C, et al. Ca2+-dependent phosphorylation of NRAMP1 by CPK21 and CPK23 facilitates manganese uptake and homeostasis in Arabidopsis. Proceedings of the National Academy of Sciences of the United States of America. 2022; 119: e2204574119.
Deng M, Chen Z, Tan J, Liu H. Down-regulation of SLC35C1 induces colon cancer through over-activating Wnt pathway. Journal of Cellular and Molecular Medicine. 2020; 24: 3079–3090.
Cooper N, Li YT, Möller A, Schulz-Weidner N, Sachs UJ, Wagner F, et al. Incidental diagnosis of leukocyte adhesion deficiency type II following ABO typing. Clinical Immunology. 2020; 221: 108599.
Chen L, Zhang J, Yang X, Liu Y, Deng X, Yu C. Lysophosphatidic acid decreased macrophage foam cell migration correlated with downregulation of fucosyltransferase 8 via HNF1α. Atherosclerosis. 2019; 290: 19–30.
Xue S, Su Z, Liu D. Immunometabolism and immune response regulate macrophage function in atherosclerosis. Ageing Research Reviews. 2023; 90: 101993.
Zhao Q, Wang Z, Meyers AK, Madenspacher J, Zabalawi M, Zhang Q, et al. Hematopoietic Cell-Specific SLC37A2 Deficiency Accelerates Atherosclerosis in LDL Receptor-Deficient Mice. Frontiers in Cardiovascular Medicine. 2021; 8: 777098.
Fang Y, Liu W, Tang Z, Ji X, Zhou Y, Song S, et al. Monocarboxylate transporter 4 inhibition potentiates hepatocellular carcinoma immunotherapy through enhancing T cell infiltration and immune attack. Hepatology. 2023; 77: 109–123.
Payen VL, Mina E, Van Hée VF, Porporato PE, Sonveaux P. Monocarboxylate transporters in cancer. Molecular Metabolism. 2020; 33: 48–66.
Cluntun AA, Badolia R, Lettlova S, Parnell KM, Shankar TS, Diakos NA, et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metabolism. 2021; 33: 629–648.e10.
Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metabolism. 2011; 13: 655–667.
Povero D, Johnson SM, Liu J. Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer. Cancer Letters. 2020; 493: 71–79.
Zhang W, Xu L, Zhu L, Liu Y, Yang S, Zhao M. Lipid Droplets, the Central Hub Integrating Cell Metabolism and the Immune System. Frontiers in Physiology. 2021; 12: 746749.
Liu R, Lee JH, Li J, Yu R, Tan L, Xia Y, et al. Choline kinase alpha 2 acts as a protein kinase to promote lipolysis of lipid droplets. Molecular Cell. 2021; 81: 2722–2735.e9.
Ma Q, Meng Z, Meng Y, Liu R, Lu Z. A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells. Cancer Communications. 2021; 41: 933–936.
Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines. International Journal of Molecular Sciences. 2021; 22: 7061.
Tam LS, Kitas GD, González-Gay MA. Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis? Rheumatology. 2014; 53: 1108-1119.
Biros E, Moran CS, Maguire J, Holliday E, Levi C, Golledge J. Upregulation of arylsulfatase B in carotid atherosclerosis is associated with symptoms of cerebral embolization. Scientific Reports. 2017; 7: 4338.
Das S, Ray R, Snehlata, Das N, Srivastava LM. Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis. Molecular and Cellular Biochemistry. 2006; 285: 143–147.
Moser MA, Chun OK. Vitamin C and Heart Health: A Review Based on Findings from Epidemiologic Studies. International Journal of Molecular Sciences. 2016; 17: 1328.
van Tuijl J, Joosten LAB, Netea MG, Bekkering S, Riksen NP. Immunometabolism orchestrates training of innate immunity in atherosclerosis. Cardiovascular Research. 2019; 115: 1416–1424.
Zhang SJ, Li ZH, Zhang YD, Chen J, Li Y, Wu FQ, et al. Ketone Body 3-Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a-Mediated Calcium Influx. Advanced Science. 2021; 8: 2003410.
Billingham LK, Stoolman JS, Vasan K, Rodriguez AE, Poor TA, Szibor M, et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nature Immunology. 2022; 23: 692–704.
Barra NG, Henriksbo BD, Anhê FF, Schertzer JD. The NLRP3 inflammasome regulates adipose tissue metabolism. The Biochemical Journal. 2020; 477: 1089–1107.
Meyers AK, Zhu X. The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging. Cells. 2020; 9: 1808.
Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN. Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD. International Journal of Molecular Sciences. 2021; 22: 6702.
Sluimer JC, Gasc JM, Hamming I, van Goor H, Michaud A, van den Akker LH, et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. The Journal of Pathology. 2008; 215: 273–279.
Batlle M, Roig E, Perez-Villa F, Lario S, Cejudo-Martin P, García-Pras E, et al. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. The Journal of Heart and Lung Transplantation. 2006; 25: 1117–1125.
Fernandez DM, Rahman AH, Fernandez NF, Chudnovskiy A, Amir EAD, Amadori L, et al. Single-cell immune landscape of human atherosclerotic plaques. Nature Medicine. 2019; 25: 1576–1588.
Sage AP, Tsiantoulas D, Binder CJ, Mallat Z. The role of B cells in atherosclerosis. Nature Reviews. Cardiology. 2019; 16: 180–196.
Foks AC, Ran IA, Wasserman L, Frodermann V, Ter Borg MND, de Jager SCA, et al. T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2013; 33: 2558–2565.
Lian C, Wang Z, Qiu J, Jiang B, Lv J, He R, et al. TIM 3 inhibits PDGF BB induced atherogenic responses in human artery vascular smooth muscle cells. Molecular Medicine Reports. 2020; 22: 886–894.
Cong Y, Wang X, Wang S, Qiao G, Li Y, Cao J, et al. Tim-3 promotes tube formation and decreases tight junction formation in vascular endothelial cells. Bioscience Reports. 2020; 40: BSR20202130.
Mulholland M, Kritikou E, Katra P, Nilsson J, Björkbacka H, Lichtman AH, et al. LAG3 Regulates T Cell Activation and Plaque Infiltration in Atherosclerotic Mice. JACC. CardioOncology. 2022; 4: 635–645.
Yousif LI, Tanja AA, de Boer RA, Teske AJ, Meijers WC. The role of immune checkpoints in cardiovascular disease. Frontiers in Pharmacology. 2022; 13: 989431.
Minami H, Nagaharu K, Nakamori Y, Ohishi K, Shimojo N, Kageyama Y, et al. CXCL12-CXCR4 Axis Is Required for Contact-Mediated Human B Lymphoid and Plasmacytoid Dendritic Cell Differentiation but Not T Lymphoid Generation. Journal of Immunology. 2017; 199: 2343–2355.
Wang J, Xie J, Wang D, Han X, Chen M, Shi G, et al. CXCR4high megakaryocytes regulate host-defense immunity against bacterial pathogens. eLife. 2022; 11: e78662.
Georgakis MK, Bernhagen J, Heitman LH, Weber C, Dichgans M. Targeting the CCL2-CCR2 axis for atheroprotection. European Heart Journal. 2022; 43: 1799–1808.
Jongstra-Bilen J, Tai K, Althagafi MG, Siu A, Scipione CA, Karim S, et al. Role of myeloid-derived chemokine CCL5/RANTES at an early stage of atherosclerosis. Journal of Molecular and Cellular Cardiology. 2021; 156: 69–78.
Apostolakis S, Spandidos D. Chemokines and atherosclerosis: focus on the CX3CL1/CX3CR1 pathway. Acta Pharmacologica Sinica. 2013; 34: 1251–1256.
de Jager SCA, Bongaerts BWC, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S, et al. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS ONE. 2012; 7: e45804.
De Sutter J, Struyf S, Van de Veire NR, Philippé J, De Buyzere M, Van Damme J. Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease. Journal of Molecular and Cellular Cardiology. 2010; 49: 894–896.
Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nature Reviews. Immunology. 2011; 11: 762–774.
Ghattas A, Griffiths HR, Devitt A, Lip GYH, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? Journal of the American College of Cardiology. 2013; 62: 1541–1551.
Gisterå A, Klement ML, Polyzos KA, Mailer RKW, Duhlin A, Karlsson MCI, et al. Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice. Circulation. 2018; 138: 2513–2526.
Backteman K, Andersson C, Dahlin LG, Ernerudh J, Jonasson L. Lymphocyte subpopulations in lymph nodes and peripheral blood: a comparison between patients with stable angina and acute coronary syndrome. PLoS ONE. 2012; 7: e32691.
Podolec J, Niewiara L, Skiba D, Siedlinski M, Baran J, Komar M, et al. Higher levels of circulating naïve CD8+CD45RA+ cells are associated with lower extent of coronary atherosclerosis and vascular dysfunction. International Journal of Cardiology. 2018; 259: 26–30.
Huang SCC, Pearce EJ. For macrophages, Ndufs is enough. Immunity. 2014; 41: 351–353.
Jin Z, Wei W, Yang M, Du Y, Wan Y. Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization. Cell Metabolism. 2014; 20: 483–498.
Schirris TJJ, Rossell S, de Haas R, Frambach SJCM, Hoogstraten CA, Renkema GH, et al. Stimulation of cholesterol biosynthesis in mitochondrial complex I-deficiency lowers reductive stress and improves motor function and survival in mice. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2021; 1867: 166062.
Li M, Xin S, Gu R, Zheng L, Hu J, Zhang R, et al. Novel Diagnostic Biomarkers Related to Oxidative Stress and Macrophage Ferroptosis in Atherosclerosis. Oxidative Medicine and Cellular Longevity. 2022; 2022: 8917947.
Zhao L, Lv F, Zheng Y, Yan L, Cao X. Characterization of an Aging-Based Diagnostic Gene Signature and Molecular Subtypes With Diverse Immune Infiltrations in Atherosclerosis. Frontiers in Molecular Biosciences. 2022; 8: 792540.
